Target intelligence / Profile preview

Dengue virus serotype 1 capsid protein (DENV-1 C)

Target
DENV-1 C
Molecular classification
Viral structural protein, RNA-binding protein
01

Overview

The Dengue virus serotype 1 (DENV-1) capsid protein is a small, highly basic structural protein that plays a critical role in the viral life cycle by packaging the viral genomic RNA into a nucleocapsid (UniProt: P17763). This protein is essential for the assembly of infectious virions, as it facilitates the interaction between the RNA genome and the viral envelope (PubMed: 26109513). Beyond its structural duties, the DENV-1 capsid protein is known to associate with host lipid droplets, a process that is vital for efficient viral replication and particle formation (PubMed: 22303105). It also translocates to the host cell nucleus, where it may interfere with host cellular processes to promote a pro-viral environment (PubMed: 11831707). As a therapeutic target, the capsid protein is highly valued because its inhibition can halt the production of new viral particles and potentially reduce viral load in patients. Small molecule inhibitors like ST-148 have demonstrated the ability to bind the capsid protein, thereby disrupting its assembly functions and providing a proof-of-concept for antiviral intervention (PubMed: 23135904). However, challenges such as the high mutation rate of the virus and the need for broad-spectrum activity across all four Dengue serotypes remain significant hurdles in drug development.

Other names
Capsid protein CCore proteinDENV1 C proteinStructural protein C
02

Mechanism of action

Inhibition of nucleocapsid assembly and disruption of capsid-lipid droplet interactions

03

Biological functions

Viral assemblyNucleocapsid formationRNA packagingHost-pathogen interactionLipid droplet association
04

Disease associations

Dengue feverDengue hemorrhagic feverDengue shock syndromeInfection
05

Safety considerations

Viral resistance mutationsSerotype-specific efficacyOff-target effects on host lipid metabolism
06

Interacting drugs

ST-148

1 more in the full profile.

07

Biomarkers

DENV-1 RNA viral load

Beyond the preview

Go deeper on Dengue virus serotype 1 capsid protein (DENV-1 C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dengue virus serotype 1 capsid protein (DENV-1 C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call